Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ANTIPLASMIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 177 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Thomas, AR; Naude, RJ; Oelofsen, W; Naganuma, T; Muramoto, K
      Purification and partial characterisation of alpha(2)-antiplasmin and plasmin(ogen) from ostrich plasma

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY
    2. Lijnen, HR
      Gene targeting in hemostasis. Alpha(2)-antiplasmin

      FRONTIERS IN BIOSCIENCE
    3. Lotz, J; Walgenbach, S; Peetz, D; Dutkowski, P; Junginger, T; Prellwitz, W; Hafner, G
      Postoperative reduction of fibrinolysis as a prognostic factor of fatal outcome

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    4. Asakura, H; Ontachi, Y; Mizutani, T; Kato, M; Ito, T; Saito, M; Morishita, E; Yamazaki, M; Suga, Y; Miyamoto, KI; Nakao, S
      Depressed plasma activity of plasminogen or alpha 2 plasmin inhibitor is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation

      BLOOD COAGULATION & FIBRINOLYSIS
    5. Ray, MJ; Hales, M; Marsh, N
      Epsilon-aminocaproic acid promotes the release of alpha(2)-antiplasmin during and after cardiopulmonary bypass

      BLOOD COAGULATION & FIBRINOLYSIS
    6. Redondo, M; Carroll, VA; Mauron, T; Biasiutti, FD; Binder, BR; Lammle, B; Wuillemin, WA
      Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: a low plasma level of plasmin-alpha 2-antiplasmin complex is an independent predictor of coronary re-events

      BLOOD COAGULATION & FIBRINOLYSIS
    7. Meddeb, B; Guermazi, S; Hafsia, R; Ben Abid, H; Gouider, E; Ben Lakhal, R; Ali, ZBH; Ben Othman, T; Jeddi, R; Dellagi, K; Hafsia, A
      Atypic defibrination's syndromes and acute leukemia with t(9,22) translocation: two cases reports

      PATHOLOGIE BIOLOGIE
    8. Siebenlist, KR; Meh, DA; Mosesson, MW
      Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin

      THROMBOSIS AND HAEMOSTASIS
    9. Paramo, JA; Orbe, J; Fernandez, J
      Fibrinolysis/proteolysis balance in stable angina pectoris in relation to angiographic findings

      THROMBOSIS AND HAEMOSTASIS
    10. Dewerchin, M; Collen, D; Lijnen, HR
      Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha(2)-antiplasmin and PAI-1

      THROMBOSIS AND HAEMOSTASIS
    11. Lee, AYY; Fredenburgh, JC; Stewart, RJ; Rischke, JA; Weitz, JI
      Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha(2)-antiplasmin

      THROMBOSIS AND HAEMOSTASIS
    12. van der Bom, JG; Bots, ML; Haverkate, F; Meijer, F; Hofman, A; Kluft, C; Grobbee, DE
      Activation products of the haemostatic system in coronary, cerebrovascularand peripheral arterial disease

      THROMBOSIS AND HAEMOSTASIS
    13. Cvirn, G; Gallistl, S; Muntean, W
      Alpha-2-macroglobulin inhibits the anticoagulant action of activated protein C in cord and adult plasma

      HAEMOSTASIS
    14. Uguralp, S; Mutus, M; Kutlu, O; Cetin, S; Baysal, T; Mizrak, B
      Primary intestinal lymphangiectasia: A rare disease in the differential diagnosis of acute abdomen

      JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
    15. Lijnen, HR; Van Hoef, BT; Collen, D
      Inactivation of the serpin alpha(2)-antiplasmin by stromelysin-1

      BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
    16. Zhou, AW; Carrell, RW; Huntington, JA
      The serpin inhibitory mechanism is critically dependent on the length of the reactive center loop

      JOURNAL OF BIOLOGICAL CHEMISTRY
    17. Favier, R; Aoki, N; de Moerloose, P
      Congenital alpha(2)-plasmin inhibitor deficiencies: a review

      BRITISH JOURNAL OF HAEMATOLOGY
    18. Nagai, N; De Mol, M; Van Hoef, B; Verstreken, M; Collen, D
      Depletion of circulating alpha(2)-antiplasmin by intravenous plasmin or immunoneutralization reduces focal cerebral ischemic injury in the absence ofarterial recanalization

      BLOOD
    19. Lijnen, HR; Van Hoef, B; Dewerchin, M; Collen, D
      alpha(2)-antiplasmin gene deficiency in mice does not affect neointima formation after vascular injury

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    20. Lijnen, HR; Collen, D
      Molecular basis of thrombolytic therapy

      JOURNAL OF NUCLEAR CARDIOLOGY
    21. Okada, K; Ueshima, S; Tanaka, M; Fukao, H; Matsuo, O
      Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha(2)-antiplasmin-deficient mice

      BLOOD COAGULATION & FIBRINOLYSIS
    22. Urano, T; Ihara, H; Takada, Y; Fujie, M; Takada, A
      The cleavage and inactivation of plasminogen activator inhibitor type 1 and alpha 2-antiplasmin by reptilase, a thrombin-like venom enzyme

      BLOOD COAGULATION & FIBRINOLYSIS
    23. Yoshinaga, H; Hirosawa, S; Chung, DH; Miyasaka, N; Aoki, N; Favier, R
      A novel point mutation of the splicing donor site in the intron 2 of the plasmin inhibitor gene

      THROMBOSIS AND HAEMOSTASIS
    24. Arza, B; Felez, J; Fabregas, P; Laroche, Y; Collen, D; Lijnen, HR
      Plasminogen binding properties of macrophage inflammatory protein (MIP)-2 alpha

      THROMBOSIS AND HAEMOSTASIS
    25. Uszynski, M; Klyszejko, A; Zekanowska, E
      Plasminogen, alpha(2)-antiplasmin and complexes of plasmin-alpha(2)-antiplasmin (PAP) in amniotic fluid and blood plasma of parturient women

      EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    26. Hevessy, Z; Patthy, A; Karpati, L; Muszbek, L
      alpha(2)-plasmin inhibitor is a substrate for tissue transglutaminase: An in vitro study

      THROMBOSIS RESEARCH
    27. Stief, TW; Hinz, F; Kurz, J; Doss, MO; Kretschmer, V
      A simple screening assay for certain fibrinolysis parameters (FIPA)

      THROMBOSIS RESEARCH
    28. Mellet, P; Bieth, JG
      Evidence that translocation of the proteinase precedes its acylation in the serpin inhibition pathway

      JOURNAL OF BIOLOGICAL CHEMISTRY
    29. Nash, P; McFadden, G; Whitty, A
      Application of linear free energy relationships to the serpin-proteinase inhibition mechanism

      FEBS LETTERS
    30. Aso, Y; Fujiwara, Y; Tayama, K; Takebayashi, K; Inukai, T; Takemura, Y
      Relationship between soluble thrombomodulin in plasma and coagulation or fibrinolysis in type 2 diabetes

      CLINICA CHIMICA ACTA
    31. Robbie, LA; Bennett, B; Keyt, BA; Booth, NA
      Effective lysis of model thrombi by a t-PA mutant (A473S) that is resistant to alpha(2)-antiplasmin

      BRITISH JOURNAL OF HAEMATOLOGY
    32. Kawasaki, T; Dewerchin, M; Lijnen, HR; Vermylen, J; Hoylaerts, MF
      Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysisduring acute arterial thrombosis in mice

      BLOOD
    33. Fitzpatrick, SL; Kassam, G; Choi, KS; Kang, HM; Fogg, DK; Waisman, DM
      Regulation of plasmin activity by annexin II tetramer

      BIOCHEMISTRY
    34. Clason, SB; Meijer, P; Kluft, C; Ersdal, E
      Specific determination of plasmin inhibitor activity in plasma: documentation of specificity of manual and automated procedures.

      BLOOD COAGULATION & FIBRINOLYSIS
    35. Johansson, J; Jensen-Urstad, K; Jensen-Urstad, M
      Antiplasmin correlates to arterial reactivity in a healthy population of 35-year-old men and women

      JOURNAL OF INTERNAL MEDICINE
    36. Mukherjee, M; DeLorenzo, F; Kadziola, Z; Rutlin, A; Ranlall, N; Sembhi, K; Dawson, G; Kakkar, VV
      Correlation of circulating 17 beta-oestradiol with haemostatic factors in healthy postmenopausal women

      HAEMOSTASIS
    37. Malukiewicz-Wisniewska, G; Kotschy, M; Kaluzny, J
      The influence of retinal detachment surgery on perioperative blood fibrinolysis

      CURRENT EYE RESEARCH
    38. Stack, MS; Gately, S; Bafetti, LM; Enghild, JJ; Soff, GA
      Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation

      BIOCHEMICAL JOURNAL
    39. Fujimoto, T; Nakamura, K; Nishihira, J
      Development of a latex immunoturbidimetric assay for the automated measurement of alpha(2) plasmin inhibitor-plasmin complex in human plasma

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    40. Fareed, J; Hoppensteadt, DA; Jeske, WP; Ahmad, S; Bick, RL
      Acquired defects of fibrinolysis associated with thrombosis

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    41. Orth, M; Mayer, H; Halle, M; Luley, C
      Hemostatic factors in hypertriglyceridemic men: Effects of a fatty meal before and after triglyceride-lowering treatment with etofibrate

      THROMBOSIS RESEARCH
    42. Muszbek, L; Yee, VC; Hevessy, Z
      Blood coagulation factor XIII: Structure and function

      THROMBOSIS RESEARCH
    43. Arumugam, S; Jang, YC; Chen-Jensen, C; Gibran, NS; Isik, FF
      Temporal activity of plasminogen activators and matrix metalloproteinases during cutaneous wound repair

      SURGERY
    44. Van Patten, SM; Hanson, E; Bernasconi, R; Zhang, K; Manavalan, P; Cole, ES; McPherson, JM; Edmunds, T
      Oxidation of methionine residues in antithrombin - Effects on biological activity and heparin binding

      JOURNAL OF BIOLOGICAL CHEMISTRY
    45. Reed, GL; Houng, AK
      The contribution of activated factor XIII to fibrinolytic resistance in experimental pulmonary embolism

      CIRCULATION
    46. Lind, B; Thorsen, S
      A novel missense mutation in the human plasmin inhibitor (alpha(2)-antiplasmin) gene associated with a bleeding tendency

      BRITISH JOURNAL OF HAEMATOLOGY
    47. Mast, AE; Stadanlick, JE; Lockett, JM; Dietzen, DJ
      Solvent/detergent-treated plasma has decreased antitrypsin activity and absent antiplasmin activity

      BLOOD
    48. Lee, KN; Tae, WC; Jackson, KW; Kwon, SH; McKee, PA
      Characterization of wild-type and mutant alpha(2)-antiplasmins: Fibrinolysis enhancement by reactive site mutant

      BLOOD
    49. Lijnen, HR; Okada, K; Matsuo, O; Collen, D; Dewerchin, M
      alpha(2)-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding

      BLOOD
    50. Sazonova, IY; Aisina, RB; Muhametova, LI; Varfolomeyev, SD
      Kinetic properties of the activator complexes plasmin-staphylokinase and plasmin(ogen)-streptokinase in vitro

      BIOCHEMISTRY-MOSCOW
    51. Bantel, H; Gregor, M; Lamberts, R
      Acute abdomen as the initial sign of primary intestinal lymphangiectasis

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    52. WINRAM SB; LOTTENBERG R
      SITE-DIRECTED MUTAGENESIS OF STREPTOCOCCAL PLASMIN RECEPTOR PROTEIN (PLR) IDENTIFIES THE C-TERMINAL LYS(334) AS ESSENTIAL FOR PLASMIN BINDING, BUT MUTATION OF THE PLR GENE DOES NOT REDUCE PLASMIN BINDING TO GROUP-A STREPTOCOCCI

      Microbiology
    53. ALAIGH P; HOFFMAN CJ; KORLIPARA G; NEUROTH A; DERVAN JP; LAWSON WE; HULTIN MB
      LIPOPROTEIN(A) LEVEL DOES NOT PREDICT RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY

      Arteriosclerosis, thrombosis, and vascular biology
    54. BALLINGER AB; FARTHING MJG
      OCTREOTIDE IN THE TREATMENT OF INTESTINAL LYMPHANGIECTASIA

      European journal of gastroenterology & hepatology
    55. LEBRAZI J; ELALAMY I; HELFT G; SAMAMA MM
      STAPHYLOKINASE MUTANTS - NEW THROMBOLYTIC AGENTS

      Journal des maladies vasculaires
    56. LEE KN; LEE SC; JACKSON KW; TAE WC; SCHWARTZOTT DG; MCKEE PA
      EFFECT OF PHENYLGLYOXAL-MODIFIED ALPHA(2)-ANTIPLASMIN ON UROKINASE-INDUCED FIBRINOLYSIS

      Thrombosis and haemostasis
    57. OZYILKAN O; BALTALI E; OZDEMIR O; TEKUZMAN G; KIRAZLI S; FIRAT D
      HEMOSTATIC CHANGES - PLASMA-LEVELS OF ALPHA2-ANTIPLASMIN-PLASMIN COMPLEX AND THROMBIN-ANTITHROMBIN-III COMPLEX IN FEMALE BREAST-CANCER

      Tumori
    58. GRAHAM DA; HUANG TC; KEYT BA; ALEVRIADOU BR
      REAL-TIME MEASUREMENT OF LYSIS OF MURAL PLATELET DEPOSITS BY FIBRINOLYTIC AGENTS UNDER ARTERIAL FLOW

      Annals of biomedical engineering
    59. NORDENHEM A; WIMAN B
      TISSUE-PLASMINOGEN ACTIVATOR (TPA) ANTIGEN IN PLASMA - CORRELATION WITH DIFFERENT TPA INHIBITOR COMPLEXES/

      Scandinavian journal of clinical & laboratory investigation
    60. RINGDAHL U; SVENSSON M; WISTEDT AC; RENNE T; KELLNER R; MULLERESTERL W; SJOBRING U
      MOLECULAR COOPERATION BETWEEN PROTEIN PAM AND STREPTOKINASE FOR PLASMIN ACQUISITION BY STREPTOCOCCUS-PYOGENES

      The Journal of biological chemistry
    61. ARAI K; MADOIWA S; MIMURO J; ASAKURA S; MATSUDA M; SAKO T; SAKATA Y
      ROLE OF THE KRINGLE DOMAIN IN PLASMINOGEN ACTIVATION WITH STAPHYLOKINASE

      Journal of Biochemistry
    62. ARONIS S; PLATOKOUKI H; PHOTOPOULOS S; ADAMTZIKI E; XANTHOU M
      INDICATIONS OF COAGULATION AND OR FIBRINOLYTIC SYSTEM ACTIVATION IN HEALTHY AND SICK VERY-LOW-BIRTH-WEIGHT NEONATES/

      Biology of the neonate
    63. JESPERS L; VANHERZEELE N; LIJNEN HR; VANHOEF B; DEMAEYER M; COLLEN D; LASTERS I
      ARGININE-719 IN HUMAN PLASMINOGEN MEDIATES FORMATION OF THE STAPHYLOKINASE-PLASMIN ACTIVATOR COMPLEX

      Biochemistry
    64. LEE SC; LEE KN; SCHWARTZOTT DG; JACKSON KW; TAE WC; MCKEE PA
      PURIFICATION OF HUMAN ALPHA(2)-ANTIPLASMIN WITH CHICKEN IGY SPECIFIC TO ITS CARBOXY-TERMINAL PEPTIDE

      Preparative biochemistry & biotechnology
    65. HELLSTERN P; BEECK H
      CLINICAL-FEATURES AND TREATMENT OF HEREDITARY AND ACQUIRED PLASMIN INHIBITOR DEFICIENCY

      Infusionstherapie und Transfusionsmedizin
    66. DABROWIECKI S; ROSC D; JURKOWSKI P
      THE INFLUENCE OF LAPAROSCOPIC CHOLECYSTECTOMY ON PERIOPERATIVE BLOOD-CLOTTING AND FIBRINOLYSIS

      Blood coagulation & fibrinolysis
    67. GUERMAZI S; KHELIF A; CONARD J; ENNABLI S; DELLAGI K
      BLEEDING SYNDROM AND ISOLATED ALPHA-2 ANT IPLASMIN DEFICIENCY - A CASE-REPORT

      Pathologie et biologie
    68. OKADA K; LIJNEN HR; DEWERCHIN M; BELAYEW A; MATSUO O; COLLEN D; BERNAERTS R
      CHARACTERIZATION AND TARGETING OF THE MURINE ALPHA(2)-ANTIPLASMIN GENE

      Thrombosis and haemostasis
    69. ROBBIE LA; YOUNG SP; BENNETT B; BOOTH NA
      THROMBI FORMED IN A CHANDLER LOOP MIMIC HUMAN ARTERIAL THROMBI IN STRUCTURE AND PAI-1 CONTENT AND DISTRIBUTION

      Thrombosis and haemostasis
    70. TACHIKAWA K; HASUMI K; ENDO A
      ENHANCEMENT OF PLASMINOGEN BINDING TO U937 CELLS AND FIBRIN BY COMPLESTATIN

      Thrombosis and haemostasis
    71. KAMPER EF; KOPEIKINA LT; KOUTSOUKOS V; STAVRIDIS J
      PLASMA TETRANECTIN LEVELS AND DISEASE-ACTIVITY IN PATIENTS WITH RHEUMATOID-ARTHRITIS

      Journal of rheumatology
    72. CHRISTENSEN S; VALNICKOVA Z; THOGERSEN IB; OLSEN EHN; ENGHILD JJ
      ASSIGNMENT OF A SINGLE DISULFIDE BRIDGE IN HUMAN ALPHA(2)-ANTIPLASMIN- IMPLICATIONS FOR THE STRUCTURAL AND FUNCTIONAL-PROPERTIES

      Biochemical journal
    73. ANDRONICOS NM; RANSON M; BOGNACKI J; BAKER MS
      THE HUMAN ENO1 GENE-PRODUCT (RECOMBINANT HUMAN ALPHA-ENOLASE) DISPLAYS CHARACTERISTICS REQUIRED FOR A PLASMINOGEN BINDING-PROTEIN

      Biochimica et biophysica acta. Protein structure and molecular enzymology
    74. YARZABAL A; BASTIDAS M; AVILAN L; CRUZ J; PUIG J
      INDUCTION CONDITIONS FOR MAXIMIZING RECOMBINANT STAPHYLOKINASE EXPRESSION IN ESCHERICHIA-COLI

      Biotechnology letters
    75. PRECETTI AS; ORIA MP; NIELSEN SS
      PRESENCE IN BOVINE-MILK OF 2 PROTEASE INHIBITORS OF THE PLASMIN SYSTEM

      Journal of dairy science
    76. SIDELMANN J; JESPERSEN J; KLUFT C; GRAM J
      THE EFFECT OF CHEMICAL ANTI-INHIBITORS ON FIBRINOLYTIC ENZYMES AND INHIBITORS

      Clinica chimica acta
    77. BUTTE AN; HOUNG AK; JANG IK; REED GL
      ALPHA(2)-ANTIPLASMIN CAUSES THROMBI TO RESIST FIBRINOLYSIS INDUCED BYTISSUE-PLASMINOGEN ACTIVATOR IN EXPERIMENTAL PULMONARY-EMBOLISM

      Circulation
    78. PAQUERON X; FAVIER R; RICHARD P; MAILLET J; MURAT I
      SEVERE POSTADENOIDECTOMY BLEEDING REVEALING CONGENITAL ALPHA(2) ANTIPLASMIN DEFICIENCY IN A CHILD

      Anesthesia and analgesia
    79. HAZNEDAROGLU IC; ERDEM Y; CELIK I; DUNDAR S; CAGLAR S; KIRAZLI S
      HAEMOSTASIC MARKERS IN AMYLOID VS NONAMYLOID UREMIC PATIENTS ON MAINTENANCE HEMODIALYSIS

      Nephrology
    80. RIES M; KLINGE J; RAUCH R; TRUSEN B; ZENKER M; KEUPER H; HARMS D
      IN-VITRO FIBRINOLYSIS AFTER ADDING LOW-DOSES OF PLASMINOGEN ACTIVATORS AND PLASMIN GENERATION WITH AND WITHOUT OXIDATIVE INACTIVATION OF PLASMIN INHIBITORS IN NEWBORNS AND ADULTS

      Journal of pediatric hematology/oncology
    81. ERDEM Y; HAZNEDAROGLU IC; CELIK I; YALCIN AU; YASAVUL U; TURGAN C; KIRAZLI S; CAGLAR S
      COAGULATION AND FIBRINOLYSIS IN AMYLOID AND NONAMYLOID HEMODIALYSIS-PATIENTS - ASSESSMENT OF LOCAL HEMOSTATIC KINETICS WITHIN ARTERIOVENOUS-FISTULAS

      Clinical and applied thrombosis/hemostasis
    82. PARRADO J; CONEJEROLARA F; SMITH RAG; MARSHALL JM; PONTING CP; DOBSON CM
      THE DOMAIN ORGANIZATION OF STREPTOKINASE - NUCLEAR-MAGNETIC-RESONANCE, CIRCULAR-DICHROISM, AND FUNCTIONAL-CHARACTERIZATION OF PROTEOLYTIC FRAGMENTS

      Protein science
    83. UESHIMA S; OKADA K; MATSUMOTO H; TAKAISHI T; FUKAO H; MATSUO O
      EFFECTS OF ENDOTHELIAL-CELLS ON ACTIVITY OF STAPHYLOKINASE

      Blood coagulation & fibrinolysis
    84. MUKHERJEE M; SEMBHI K; KAKKAR VV
      INTERFERENCE OF AN ACTIVITY ASSAY OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN HUMAN PLASMA BY ENDOGENOUS FACTORS

      Blood coagulation & fibrinolysis
    85. NOWAKGOTTL U; WERBER G; ZIEMANN D; AHLKE E; BOOS J
      INFLUENCE OF 2 DIFFERENT ESCHERICHIA-COLI ASPARAGINASE PREPARATIONS ON FIBRINOLYTIC PROTEINS IN CHILDHOOD ALL

      Haematologica
    86. OKADA K; UESHIMA S; TAKAISHI T; YUASA H; FUKAO H; MATSUO O
      EFFECTS OF FIBRIN AND ALPHA(2)-ANTIPLASMIN ON PLASMINOGEN ACTIVATION BY STAPHYLOKINASE

      American journal of hematology
    87. ROBBIE LA; BENNETT B; CROLL AM; BROWN PAJ; BOOTH NA
      PROTEINS OF THE FIBRINOLYTIC SYSTEM IN HUMAN THROMBI

      Thrombosis and haemostasis
    88. KOLEV K; KOMOROWICZ E; OWEN WG; MACHOVICH R
      QUANTITATIVE COMPARISON OF FIBRIN DEGRADATION WITH PLASMIN, MINIPLASMIN, NEUROPHIL LEUKOCYTE ELASTASE AND CATHEPSIN-G

      Thrombosis and haemostasis
    89. SCHAEFER BM; MAIER K; EICKHOFF U; BECHTEL M; KRAMER MD
      ALPHA(2)-ANTIPLASMIN AND PLASMINOGEN-ACTIVATOR INHIBITORS IN HEALING HUMAN SKIN WOUNDS

      Archives of dermatological research
    90. LIJNEN HR; COLLEN D
      STAPHYLOKINASE, A FIBRIN-SPECIFIC BACTERIAL PLASMINOGEN-ACTIVATOR

      Fibrinolysis
    91. TVEDSKOV TF; VAD H; ALBRECHTSEN OK; GRAM J
      TISSUE THROMBOPLASTIN INDUCES RAPID INHIBITION OF FIBRINOLYSIS IN RABBITS

      Fibrinolysis
    92. LIJNEN HR; SILENCE K; HARTMANN M; GUHRS KH; GASE A; SCHLOTT B; COLLEN D
      FIBRINOLYTIC PROPERTIES OF STAPHYLOKINASE MUTANTS OBTAINED BY CLUSTERED CHARGE-TO-ALANINE MUTAGENESIS

      Fibrinolysis
    93. LEEBEEK FWG; LOS P; KLUFT C
      A MONOCLONAL-ANTIBODY AGAINST THE COOH-TERMINAL SITE OF ALPHA(2)-ANTIPLASMIN REVEALS HETEROGENEITY IN THE NONPLASMINOGEN BINDING FORM OF ALPHA(2)-ANTIPLASMIN

      Fibrinolysis
    94. CLASON SB; MEIJER P; KLUFT C; ERSDAL E
      A NOVEL METHOD, COAMATIC(R) PLASMIN INHIBITOR, FOR THE SPECIFIC DETERMINATION OF PLASMIN INHIBITOR ACTIVITY IN PLASMA

      Fibrinolysis
    95. WRIGHT HT
      THE STRUCTURAL PUZZLE OF HOW SERPIN SERINE PROTEINASE-INHIBITORS WORK

      BioEssays
    96. HENRIKSSON AE; NILSSON TK; JANSSON U; BERGQVIST D
      EXPERIMENTAL HEMORRHAGE AND BLOOD COMPONENT TRANSFUSION IN HUMANS - NO CHANGE IN PLASMA-CONCENTRATION OF THROMBIN-ANTITHROMBIN COMPLEX AND PLASMIN-ANTIPLASMIN COMPLEX

      Thrombosis research
    97. IKEMATSU S; FUKUTAKE K; AOKI N
      HETEROZYGOTE FOR PLASMIN INHIBITOR DEFICIENCY DEVELOPING HEMORRHAGIC TENDENCY WITH ADVANCING AGE

      Thrombosis research
    98. MALEK NP; OCRAN K; TIETGE UJF; MASCHEK H; GRATZ KF; TRAUTWEIN C; WAGNER S; MANNS MP
      A CASE OF THE YELLOW NAIL SYNDROME-ASSOCIATED WITH MASSIVE CHYLOUS ASCITES, PLEURAL AND PERICARDIAL-EFFUSIONS

      Zeitschrift fur Gastroenterologie
    99. MIYAUCHI Y; MII Y; AOKI M; TAMAI S; TAKAHASHI Y; YOSHIOKA A
      OPERATIVE TREATMENT OF INTRAMEDULLARY HEMATOMA ASSOCIATED WITH CONGENITAL DEFICIENCY OF ALPHA(2)-PLASMIN INHIBITOR - A REPORT OF 3 CASES

      Journal of bone and joint surgery. American volume
    100. SAKHAROV DV; LIJNEN HR; RIJKEN DC
      INTERACTIONS BETWEEN STAPHYLOKINASE, PLASMIN(OGEN), AND FIBRIN - STAPHYLOKINASE DISCRIMINATES BETWEEN FREE PLASMINOGEN AND PLASMINOGEN BOUND TO PARTIALLY DEGRADED FIBRIN

      The Journal of biological chemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 03:53:06